Results 191 to 200 of about 138,770 (367)

The cdk/pRB/E2F pathway in human cancer [PDF]

open access: bronze, 1999
William G. Kaelin
openalex   +1 more source

Tumour Cell Size Control and Its Impact on Tumour Cell Function

open access: yesCell Proliferation, EarlyView.
The regulatory mechanism of the size of tumour cells and its impact on the functions of tumour cells, as well as a summary of potential therapeutic targets for the corresponding mechanisms. ABSTRACT Cell size is an important component of cell morphological characteristics.
Min Zhou, Mei Zhou, Yang Jin
wiley   +1 more source

Size matters: Establishing a cut‐off for rectal neuroendocrine neoplasm to predict recurrence and standardize surveillance guidelines

open access: yesDigestive Endoscopy, EarlyView.
Objectives This study aimed to identify risk factors for recurrence of rectal neuroendocrine neoplasms, establish a cut‐off size for recurrence prediction, and standardize surveillance guidelines. Methods This retrospective study analyzed patients diagnosed with rectal neuroendocrine neoplasm at Samsung Medical Center from January 2007 to July 2021 ...
Seijong Kim   +11 more
wiley   +1 more source

d‐amino acids: new functional insights

open access: yesThe FEBS Journal, EarlyView.
This review explores recent advances in understanding d‐amino acids (d‐AAs) and their pivotal roles across organisms, from plants to humans. d‐AAs have been implicated in key physiological processes, including cancer, inflammation, immune regulation, kidney disease, diabetes, and nervous system function.
Loredano Pollegioni   +5 more
wiley   +1 more source

Evidence of substrate control of Cdk phosphorylation during the budding yeast cell cycle

open access: yesCell Reports
Summary: A series of sequential events orchestrates cell growth and division, set in motion by cyclin-dependent kinases (Cdks). In the “qualitative model” for Cdk control, order is achieved by cell cycle stage-specific cyclins.
Luca Takacs   +4 more
doaj  

Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer

open access: yesAnnals of Oncology, 2017
R. Condorelli   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy